ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
LLNL, Ampera partner to develop thorium-based TRISO fuel
Lawrence Livermore National Laboratory has formed a strategic partnership with Ampera to develop the company’s nuclear fuel concept through a project named THUNDER, for Thorium Unimodal Droplet Ejection for Reactors.
The focus of THUNDER is fabricating TRISO made with kernels of thorium rather than the usual uranium. LLNL and Ampera will evaluate and optimize liquid metal–jetting technology to produce highly uniform, spherical kernels of thorium-232 for later processing into TRISO fuel.
Nisy E. Ipe
Nuclear Technology | Volume 168 | Number 2 | November 2009 | Pages 559-563
Shielding Materials | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (Part 2) / Radiation Protection | doi.org/10.13182/NT09-A9243
Articles are hosted by Taylor and Francis Online.
A typical particle therapy facility consists of an injector, a cyclotron or a synchrotron, a high-energy transport beam line, several treatment rooms including fixed-beam and gantry rooms, and even a research area. During the operation of these facilities, radiation is produced with neutrons being the dominant component outside the shielding. These facilities have large amounts of shielding with concrete thicknesses ranging up to [approximately]5 m or more. Space required for shielding can be minimized by using composite shielding or high-density material such as Ledite® (manufactured by Atomic International, Frederick, Pennsylvania). Transmission data for radiation from protons and carbon ions incident on tissue targets with energies in the therapeutic energy range of interest were derived using the Monte Carlo code FLUKA for three different compositions of Ledite. Use of Ledite® or composite shielding results in space savings when compared to concrete.